RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. C03/246
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 119
2009
-
Molecular pathology of the fibroblast growth factor family.
Human Mutation, year: 2009, volume: 30, edition: 9, DOI
2008
-
A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells
HUMAN MOLECULAR GENETICS, year: 2008, volume: 18, edition: 11
-
Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage
PLoS ONE., year: 2008, volume: 3, edition: 12
-
STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes
JOURNAL OF CELL SCIENCE, year: 2008, volume: 121, edition: 3
2007
-
C-natriuretic peptide: an important regulator of cartilage.
Molecular Genetics and Metabolism, year: 2007, volume: 92, edition: 3, DOI
-
Fibroblast growth factors 1, 2, 17, and 19 are the predominant FGF ligandsexpressed in human fetal growth plate cartilage.
Pediatric Research, year: 2007, volume: 61, edition: 3, DOI
-
Simple, mammalian cell-based assay for identification of inhibitors of the ErkMAP kinase pathway.
Investigational New Drugs, year: 2007, volume: 25, edition: 4, DOI
-
The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia.
Journal of Leukocyte Biology, year: 2007, volume: 82, edition: 6, DOI
2006
-
Bisindolylmaleimide I suppresses fibroblast growth factor-mediated activation of Erk MAP kinase in chondrocytes by preventing Shp2 association with the Frs2 and Gab1 adaptor proteins.
Journal of Biological Chemistry, year: 2006, volume: 282, edition: 5, DOI
-
The fibroblast growth factors in multiple myeloma
Leukemia, year: 2006, volume: 20, edition: 6, DOI